Filing Details

Accession Number:
0001179110-20-010507
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-16 16:38:36
Reporting Period:
2020-10-15
Accepted Time:
2020-10-16 16:38:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1650664 Editas Medicine Inc. EDIT Biological Products, (No Disgnostic Substances) (2836) 464097528
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1682323 Charles Albright C/O Editas Medicine, Inc.
11 Hurley St.
Cambridge MA 02141
Evp/Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-10-15 3,000 $31.39 25,135 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020.
  2. This transaction was executed in multiple trades at prices ranging from $30.88 to $31.77. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.